Ross\Johnson & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254 Hold
3
﹤0.01% 201
2026
Q1
$251 Sell
3
-7
-70% -$527 ﹤0.01% 160
2025
Q4
$670 Buy
10
+7
+233% +$453 0.01% 121
2025
Q3
$203 Hold
3
﹤0.01% 170
2025
Q2
$224 Sell
3
-29
-91% -$1.93K ﹤0.01% 162
2025
Q1
$2.01K Buy
+32
New +$1.98K 0.03% 167

Other funds holding CTVA

Ross\Johnson & Associates's CTVA Position: Q2 2026 in Review

Ross\Johnson & Associates held its Corteva (CTVA) position steady in Q2 2026 at 3 shares worth $254. The position accounts for ﹤0.01% of the portfolio, ranked #201.

Ross\Johnson & Associates first reported a position in CTVA in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.01K in Q1 2025. 1,492 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Ross\Johnson & Associates held 3 shares of Corteva worth $254 as of Q2 2026.
  • Ross\Johnson & Associates left its Corteva share count unchanged in Q2 2026.
  • Corteva made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #201 holding.
  • Ross\Johnson & Associates first reported a position in Corteva in Q1 2025 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Corteva position peaked at $2.01K in Q1 2025.
  • 1,492 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.